Skip to main content
Krka logo

Krka — Investor Relations & Filings

Ticker · KRKG ISIN · SI0031102120 LEI · 549300H9RLRTRTLRUZ73 LJSE Manufacturing
Open in API
Filings indexed 1,887 across all filing types
Latest filing 2025-10-13 Transaction in Own Shar…
Country SI Slovenia
Listing LJSE KRKG

About Krka

https://www.krka.biz/en/

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Recent filings

Filing Released Lang Actions
Detailed report on acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document provides a detailed, itemized list of specific share transactions (date, time, volume, and price) executed by the company 'Krka, d. d.' regarding the acquisition of its own treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buyback reports.
2025-10-13 English
Acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is an 'Acquisition of treasury shares' and provides a detailed breakdown of share buy-back transactions conducted by Krka, d. d. between October 3 and October 9, 2025. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-10-13 English
Podrobno poročilo o nakupih lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document is titled 'Podrobno poročilo o nakupih lastnih delnic' (Detailed report on share buybacks) and contains a granular list of transaction dates, times, volumes, and prices for the company's own shares. This directly matches the definition for 'Transaction in Own Shares' (POS).
2025-10-13 English
Pridobivanje lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Krka, d.d. regarding the acquisition of its own shares (share buyback) over a specific period (October 3 to October 9, 2025). It details the number of shares purchased, the average prices, and the total impact on the company's treasury shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-10-13 Slovene
Conclusion regarding perindopril litigation
Legal Proceedings Report Classification · 100% confidence The document is a short announcement regarding the conclusion of a specific legal dispute (perindopril litigation) involving the company. It references Article 17 of Regulation (EU) No 596/2014 (Market Abuse Regulation) and provides details on the settlement of a court case. Since it pertains to a specific legal matter and litigation outcome, it fits the 'Legal Proceedings Report' category.
2025-10-08 English
Odločitev Komisije EU v zadevi perindopril
Legal Proceedings Report Classification · 100% confidence The document is a short announcement regarding the conclusion of a legal dispute (perindopril case) before the EU Court of Justice. It references Article 17 of the EU Market Abuse Regulation (MAR) regarding inside information. Since it details a specific legal outcome and regulatory matter rather than a financial report or a routine publication notice, it falls under the category of legal proceedings/regulatory updates.
2025-10-08 Slovene

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.